Cardiac MRI in Ischemic Stroke Study

The purpose of this prospective single-center trial is to compare the safety and diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging and transesophageal echocardiography in patients with acute ischemic stroke.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany

About this study

Primary safety objective: Contrast medium-enhanced cardiac magnetic resonance imaging is safe in patients with acute ischemic stroke. Primary outcome: The diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging is comparable to transesophageal echocardiography in patients with acute ischemic stroke.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with acute ischemic stroke detected by brain magnetic resonance imaging.

Exclusion criteria

Known atrial fibrillation or cardiac source of embolism
Severe aphasia
Acute infection or chronic inflammation
Severe arteriosclerosis or stenosis of brain-supplying arteries
Contraindications for magnetic resonance imaging or transesophageal echocardiography.

Treatment and study plan

Primary outcomes

Sensitivity and specificity of contrast medium-enhanced cardiac magnetic resonance imaging to detect echocardiography-proven cardiac sources of embolism in patients with acute ischemic stroke.

Time frame: < 1 week after ischemic stroke

Secondary outcomes

Rate of unrecognised myocardial infarction detected by late gadolinium-enhanced cardiac MRI in patients with acute ischemic stroke.

Time frame: < 1 week after ischemic stroke

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Collaborators

Cardiology and Angiology, Elisabeth Hospital, Essen, Germany
Center for Stroke Research Berlin

Registry information

Acronym: CaMriSS

Important dates

Study start: 2012
Primary completion: 2014
Study completion: 2014
First posted: Aug 7, 2013
Registry last updated: Nov 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed